Enoxaparin sodium biosimilar (Techdow)

依诺肝素钠生物类似药（Techdow）

Report date: 2023/12/05 13:35:12

Base Information

Drug NameEnoxaparin sodium biosimilar (Techdow)
Drug Alias Name依诺肝素钠生物仿制药（Techdow）Enoxaparina de sodio (Techdow)Enoxaparinum natricum (Techdow)Inhixa
ClassificationNatural product/Extract > Animal extractBiologics > Biosimilar
Mechanisms of ActionAntithrombin-III activatorsFactor Xa inactivationThrombin inactivation
TargetsAntithrombin-IIIProthrombinCoagulation factor X
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Blood Coagulation DisordersVenous Thrombosis +[10] 
Global Approved IndicationsVenous ThrombosisVenous ThromboembolismEmbolism and Thrombosis +[6] 
Approved Indications in ChinaEmbolism and Thrombosis
Original Approved Country/TerritoryMainland China
Original Approved Date2005/08/18
Country/TerritoryItalyEUMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenzhen Techdow Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTechdow Pharma Netherlands BvIRCCS Azienda Ospedaliero-Universitaria di BolognaShenzhen Techdow Pharmaceutical Co Ltd
Inactive CompaniesAzienda Ospedaliero-Universitaria Di Modena
Active IndicationsCoronavirus Disease 2019 (COVID-19)Venous ThrombosisVenous Thromboembolism +[7] 
Inactive IndicationsBlood Coagulation DisordersCoronavirus InfectionsPneumonia, Viral

Other Information

ATC CodeB01AB05
Related LinksN/A